334 related articles for article (PubMed ID: 26468004)
1. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of Mitoxantrone-loaded Superparamagnetic Iron Oxide Nanoparticles in a HT-29 Tumour Spheroid Model.
Hornung A; Poettler M; Friedrich RP; Weigel B; Duerr S; Zaloga J; Cicha I; Alexiou C; Janko C
Anticancer Res; 2016 Jun; 36(6):3093-101. PubMed ID: 27272833
[TBL] [Abstract][Full Text] [Related]
3. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.
Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C
Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393
[TBL] [Abstract][Full Text] [Related]
4. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
[TBL] [Abstract][Full Text] [Related]
6. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
7. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S
Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199
[TBL] [Abstract][Full Text] [Related]
9. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
10. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
Zaloga J; Janko C; Nowak J; Matuszak J; Knaup S; Eberbeck D; Tietze R; Unterweger H; Friedrich RP; Duerr S; Heimke-Brinck R; Baum E; Cicha I; Dörje F; Odenbach S; Lyer S; Lee G; Alexiou C
Int J Nanomedicine; 2014; 9():4847-66. PubMed ID: 25364244
[TBL] [Abstract][Full Text] [Related]
11. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Pernal S; Wu VM; Uskoković V
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
15. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
16. Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP).
Mieloch AA; Żurawek M; Giersig M; Rozwadowska N; Rybka JD
Sci Rep; 2020 Feb; 10(1):2725. PubMed ID: 32066785
[TBL] [Abstract][Full Text] [Related]
17. Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers.
Saxena N; Agraval H; Barick KC; Ray D; Aswal VK; Singh A; Yadav UCS; Dube CL
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110792. PubMed ID: 32279785
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.
Ling G; Zhang T; Zhang P; Sun J; He Z
Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation.
Nguyen K; Nuß B; Mühlberger M; Unterweger H; Friedrich RP; Alexiou C; Janko C
Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32796757
[TBL] [Abstract][Full Text] [Related]
20. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.
Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B
Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
